Other Income/Expenses (Net)

-$13.20M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$13.20Mperiod endingJun 30, 2026

MYGN Other Income/Expenses (Net) ($8.90M → -$13.20M)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

MYGN other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period ending	Other Income/Expenses (Net) (USD)
Dec 31, 2025	-327,300,000
Dec 31, 2024	-35,500,000
Dec 31, 2023	-117,600,000
Dec 31, 2022	-16,900,000
Dec 31, 2021	133,400,000
Dec 31, 2020	-88,900,000
Jun 30, 2020	8,400,000
Jun 30, 2019	-7,600,000
Jun 30, 2018	-1,800,000
Jun 30, 2017	-7,800,000
Jun 30, 2016	2,600,000
Jun 30, 2015	700,000
Jun 30, 2014	3,400,000
Jun 30, 2013	5,300,000
Jun 30, 2012	4,222,000
Jun 30, 2011	1,873,000
Jun 30, 2010	5,759,000
Jun 30, 2009	9,985,000
Jun 30, 2008	13,389,000
Jun 30, 2007	47,727,000
Jun 30, 2006	7,400,000
Jun 30, 2005	767,000
Jun 30, 2004	2,015,000
Jun 30, 2003	2,938,000
Jun 30, 2002	5,170,397
Jun 30, 2001	6,545,345
Jun 30, 2000	11,547,127
Jun 30, 1999	12,400,000
Jun 30, 1998	13,000,000
Jun 30, 1997	12,500,000
Jun 30, 1996	8,900,000